EP Patent

EP1682109B1 — The use of 1-aminocyclohexane derivatives to modify deposition of fibrillogenic as peptides in amyloidopathies

Assigned to Merz Pharma GmbH and Co KGaA · Expires 2008-10-15 · 18y expired

What this patent protects

Patent listed against donepezil-hydrochloride.

Drugs covered by this patent

donepezil-hydrochloride (DONEPEZIL HYDROCHLORIDE)

Patent Metadata

Patent number: EP1682109B1
Jurisdiction: EP
Classification: —
Expires: 2008-10-15
Drug substance claim: No
Drug product claim: No
Assignee: Merz Pharma GmbH and Co KGaA
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.